Group One Trading
SKYE icon

Group One Trading’s Skye Bioscience SKYE Stock Holding History

Group One Trading’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46K Buy
4,000
+3,500
+700% +$2.85K ﹤0.01% 6987
2025
Q4 		$375 Sell
500
-1,700
-77% -$2.48K ﹤0.01% 7838
2025
Q3 		$8.65K Buy
2,200
+500
+29% +$1.89K ﹤0.01% 7258
2025
Q2 		$7.11K Buy
+1,700
New +$3.52K ﹤0.01% 6922

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's SKYE Position: Q1 2026 in Review

Group One Trading reduced its Skye Bioscience (SKYE) stake by 59% in Q1 2026, selling an estimated $8.55K and leaving 7,205 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #6756.

Group One Trading first reported a position in SKYE in Q3 2025 and has held it in 3 quarters since. The position peaked at $13.3K in Q4 2025. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Group One Trading held 7,205 shares of Skye Bioscience worth $4.43K as of Q1 2026.
  • Group One Trading sold 10,492 Skye Bioscience shares in Q1 2026, an estimated $8.55K.
  • Skye Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6756 holding.
  • Group One Trading first reported a position in Skye Bioscience in Q3 2025 and has held it in 3 quarters since.
  • Group One Trading's Skye Bioscience position peaked at $13.3K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.